Loading company…
Orasis Pharmaceuticals Ltd, based in Herzliya, develops ophthalmic treatments, including Qlosi for presbyopia.
Founded in 2015 and based in Herzliya, Israel, Orasis Pharmaceuticals Ltd develops eye treatments. Its prescription product Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% treats presbyopia, the age-related loss of near focus, and is available in the US through pharmacies such as BlinkRx and Medvantx. In October 2024 it raised USD 68.00 mn in Series D funding, led by investors including Johnson & Johnson Innovation and Arboretum Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in